BHVN Biohaven Ltd.

Biohaven Announces FDA Acceptance of Vyglxia NDA Resubmission for SCA

Biohaven Ltd. announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) resubmission for Vyglxia (troriluzole) for...